IP Library Granted Patent US 12,193,901
Granted Patent B2
US 12,193,901 · App. 18/359,681 · Granted Jan 14, 2025

Dental medicament applicator

Inventors: Tyler Ferris (Boerne, TX); Jeff Reeh (Boerne, TX)
Assignee: Cav-Aid LLC
A61C19/063A61K8/21A61Q11/00A61K2800/87A61K2800/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,193,901
App. No.
18/359,681
Granted
Jan 14, 2025
Kind
B2
Abstract

A dental medicament applicator is disclosed. In one embodiment, a placement device is sized for insertion at a dental site, such as an interproximal site. The placement device includes a central body and at least one active matrix secured to the central body containing a topical substance, such as a fluoride-containing chemical agent, silver diamine fluoride, or a peptide-based chemical agent, for example. One or two wings extend from the central body to provide subterminal opposition surfaces to hold the placement device during placement. The one or more wings are free of the topical substance. The active matrix, in response to being physically affixed to the dental site, delivers the topical substance at a controlled rate to the dental site while the placement device dissolves at a quicker controlled rate.

Claims (49)

1. A dental medicament applicator comprising:

a placement device sized for insertion at a dental site, the dental site comprising an interproximal site, the placement device comprised of hydroxypropyl methyl cellulose (HPMC) polymers, the placement device comprising a central body, a first wing, and a second wing;

the central body having a front, a rear, an upper end, a lower end, a first lateral end, and a second lateral end;

the first wing having a proximal end and a distal end, the first wing being coupled to the first lateral end, the first wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the first wing therebetween, the first wing having a transverse axis from the distal end to the proximal end, a first transverse length along the transverse axis, the first transverse length being greater than twice the mean width for a human tooth, the first wing being free of a topical substance for treating incipient lesions;

the second wing having a proximal end and a distal end, the second wing being coupled to the second lateral end, the second wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the second wing therebetween, the second wing having a transverse axis from the distal end to the proximal end, a second transverse length along the transverse axis, the second transverse length being greater than twice the mean width for a human tooth, the second wing being free of the topical substance;

at least one active matrix secured to the front of the central body, the at least one active matrix comprised of pullulan polymers containing the topical substance;

each of the first wing and the second wing having a larger surface area than the at least one active matrix;

the placement device, in response to being physically affixed to the dental site, dissolving at a first controlled rate;

the at least one active matrix, in response to being physically affixed to the dental site, delivering the topical substance at a second controlled rate to the dental site, the second controlled rate being slower in time than the first controlled rate; and

the at least one active matrix dissolving to a gelatinous state at a first controlled rate, such that the dental medicament applicator is fully dissolving following the dissolution of the placement device at the first controlled rate and the delivery of the topical substance at the second controlled rate.

2. The dental medicament applicator as recited in claim 1 , wherein the central body and the first wing are at least partially integrated.

3. The dental medicament applicator as recited in claim 1 , wherein the central body and the first wing are integral.

4. The dental medicament applicator as recited in claim 1 , wherein the central body and the at least one active matrix are at least partially integrated.

5. The dental medicament applicator as recited in claim 1 , wherein the central body and the at least one active matrix are integral.

6. The dental medicament applicator as recited in claim 1 , wherein the first wing further comprises a proximal viewing area interposed between the central body and the subterminal opposition surfaces.

7. The dental medicament applicator as recited in claim 1 , wherein each of the first and second wings have a first transparency and the at least one active matrix has a second transparency, the first transparency being more transparent than the second transparency.

8. The dental medicament applicator as recited in claim 1 , wherein the mean width for a human tooth is less than 10 mm.

9. The dental medicament applicator as recited in claim 1 , wherein each of the first and second wings comprise a shape selected from the group consisting of single lobes, double lobes, polygon forms, and rectangular forms.

10. The dental medicament applicator as recited in claim 1 , wherein the placement device further comprises a material selected from the group consisting of biodegradable materials, bioresorbable materials, and resorbable materials.

11. The dental medicament applicator as recited in claim 1 , wherein the at least one matrix further comprises a material selected from the group consisting of biodegradable materials, bioresorbable materials, and resorbable materials.

12. The dental medicament applicator as recited in claim 1 , wherein the topical substance further comprises a fluoride-containing chemical agent.

13. The dental medicament applicator as recited in claim 1 , wherein the topical substance further comprises silver diamine fluoride.

14. The dental medicament applicator as recited in claim 1 , wherein the topical substance further comprises a peptide-based chemical agent.

15. The dental medicament applicator as recited in claim 1 , wherein the topical substance further comprises a peptide-based chemical agent, the peptide-based chemical agent including a combination of amelogenin, a fluoride-containing chemical agent, a calcium-containing chemical agent, and a phosphate-containing chemical agent.

16. The dental medicament applicator as recited in claim 1 , wherein the first controlled rate is about 20 seconds to about 60 seconds.

17. The dental medicament applicator as recited in claim 1 , wherein the second controlled rate is about 30 minutes to about 90 minutes.

18. A dental medicament applicator comprising:

a placement device sized for insertion at a dental site, the dental site being an interproximal site, the placement device comprised of hydroxypropyl methyl cellulose (HPMC) polymers, the placement device comprising a central body, a first wing, and a second wing;

the central body having a front, a rear, an upper end, a lower end, a first lateral end, and a second lateral end;

the first wing having a proximal end and a distal end, the first wing being coupled to the first lateral end, the first wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the first wing therebetween, the first wing having a transverse axis from the distal end to the proximal end, a first transverse length along the transverse axis, the first transverse length being greater than twice the mean width for a human tooth, the first wing being free of a topical substance for treating incipient lesions;

the second wing having a proximal end and a distal end, the second wing being coupled to the second lateral end, the second wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the second wing therebetween, the second wing having a transverse axis from the distal end to the proximal end, a second transverse length along the transverse axis, the second transverse length being greater than twice the mean width for a human tooth, the second wing being free of the topical substance;

at least one active matrix secured to the front of the central body, the at least one active matrix being pullulan polymers containing the topical substance, the at least one active matrix being bonded to the central body of the placement device by water activation followed by pressure to seal the active matrix to the central body;

each of the first and second wings having a first transparency and the at least one active matrix having a second transparency, the first transparency being more transparent than the second transparency;

each of the first wing and the second wing having a larger surface area than the at least one active matrix;

the placement device, in response to being physically affixed to the dental site, dissolving at a first controlled rate;

the first controlled rate being about 20 seconds to about 60 seconds and the second controlled rate is about 30 minutes to about 90 minutes;

the at least one active matrix, in response to being physically affixed to the dental site, delivering the topical substance at a second controlled rate to the dental site, the second controlled rate being slower in time than the first controlled rate; and

the at least one active matrix dissolving to a gelatinous state at the first controlled rate and in the gelatinous state adhering to the dental site, the dental medicament applicator dissolving following the dissolution of the placement device at the first controlled rate and the delivery of the topical substance at the second controlled rate.

19. A dental medicament applicator comprising:

a placement device sized for insertion at a dental site, the dental site being an interproximal site, the placement device consisting essentially of hydroxypropyl methyl cellulose (HPMC) polymers, the placement device comprising a central body, a first wing, and a second wing;

the central body having a front, a rear, an upper end, a lower end, a first lateral end, and a second lateral end;

the first wing having a proximal end and a distal end, the first wing being coupled to the first lateral end, the first wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the first wing therebetween, the first wing having a transverse axis from the distal end to the proximal end, a first transverse length along the transverse axis, the first transverse length being greater than twice the mean width for a human tooth, the first wing being free of a topical substance for treating incipient lesions;

the second wing having a proximal end and a distal end, the second wing being coupled to the second lateral end, the second wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the second wing therebetween, the second wing having a transverse axis from the distal end to the proximal end, the second transverse length being greater than twice the mean width for a human tooth, the second wing being free of the topical substance;

at least one active matrix secured to the front of the central body, the at least one active matrix consisting essentially of pullulan polymers containing the topical substance, the at least one active matrix being bonded to the central body of the placement device by water activation followed by pressure to seal the active matrix to the central body;

each of the first wing and the second wing having a larger surface area than the at least one active matrix;

the placement device, in response to being physically affixed to the dental site, dissolving at a first controlled rate;

the at least one active matrix, in response to being physically affixed to the dental site, delivering the topical substance at a second controlled rate to the dental site, the second controlled rate being slower in time than the first controlled rate;

the first controlled rate being about 20 seconds to about 60 seconds and the second controlled rate is about 30 minutes to about 90 minutes; and

the at least one active matrix dissolving to a gelatinous state at the first controlled rate and in the gelatinous state adhering to the dental site, the dental medicament applicator dissolving following the dissolution of the placement device at the first controlled rate and the delivery of the topical substance at the second controlled rate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2023
From: FERRIS, TYLER; REEH, JEFF
To: CAV-AID LLC
Reel/Frame 064399/0907 →
Continuity (5)
Continuation 17929081 · Sep 1, 2022
Continuation In Part 17668840 · Feb 10, 2022
Provisional Application 63147751 · Feb 10, 2021
Related Publication 20230404731A1 · Dec 21, 2023
Related Publication 20240197456A9 · Jun 20, 2024
References Cited (36)
US 4568535A · Loesche · 1986 [cited by applicant]
US 5049077A · Goldin · 1991 [cited by applicant]
US 5087200A · Brajnovic et al. · 1992 [cited by applicant]
US 5154612A · Carlsson et al. · 1992 [cited by applicant]
US 6287120B1 · Wiesel · 2001 [cited by examiner]
US 6827575B1 · Jorneus · 2004 [cited by applicant]
US 7056118B2 · Allred et al. · 2006 [cited by applicant]
US 7118376B2 · Jodaikin et al. · 2006 [cited by applicant]
US D549829S · Jodaikin et al. · 2007 [cited by applicant]
US D553245S · Jodaikin et al. · 2007 [cited by applicant]
US 7491058B2 · Jorneus et al. · 2009 [cited by applicant]
US D605773S · Jodaikin et al. · 2009 [cited by applicant]
US 7850453B2 · Jodaikin et al. · 2010 [cited by applicant]
US 7883336B2 · Hansson · 2011 [cited by applicant]
US 8287277B2 · Jodaikin et al. · 2012 [cited by applicant]
US 9668844B2 · Jodaikin et al. · 2017 [cited by applicant]
US 10849729B2 · Sagel et al. · 2020 [cited by applicant]
US 11439489B2 · Ferris et al. · 2022 [cited by applicant]
US 20050175959A1 · Jodaikin · 2005 [cited by examiner]
US 20050196727A1 · Jessop · 2005 [cited by applicant]
US 20050239015A1 · Dragan · 2005 [cited by applicant]
US 20100203467A1 · Karazivan · 2010 [cited by examiner]
US 20110200972A1 · Mythen · 2011 [cited by examiner]
US 20150125810A1 · Jodaikin · 2015 [cited by applicant]
US 20150290122A1 · Boe · 2015 [cited by applicant]
US 20210000579A1 · Higdon · 2021 [cited by applicant]
US 20210186672A1 · Wandera · 2021 [cited by examiner]
US 20220249217A1 · Ferris et al. · 2022 [cited by applicant]
DE 202009009789 · 2009 [cited by applicant]
EP 1263347 · 2007 [cited by applicant]
WO 2017182425 · 2017 [cited by applicant]
https://www.smilecareplymouth.co.uk/blog/what-is-the-average-length-of-the-teeth-importance-in-dental-aesthetics/#:˜:text=So%20that%3A,and%20in%20women%206.13%20millimeters. (Year: 2023). [cited by examiner]
Hal Open Science (a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents)[online]. [retrieved Mar. 28, 2024]. Retrieved from the Internet: https://inria.hal.science/h… [cited by examiner]
Shutz Dental Micerium Group, Impla Interim Implant, Impla temp.implant, 3,3/11,5mm, 10pcs, The Interim Implant, for securely fixing drilling templates and temporary bridges, date accessed Jul. 7, 2011, 1 page, Rosbach, … [cited by applicant]
WIPO International Search Report and Written Opinion of the International Searching Authority for PCT/US2022/016006 dated May 6, 2022. [cited by applicant]
Chong et al., “Slow-release fluoride devices for the control of dental decay (Review).” Cochrane Database of Systematic Reviews 2018, Issue 3, (Year: 2018). [cited by applicant]